Publications by authors named "Jiankang Mu"

Personalized cancer vaccines based on resected tumors from patients is promising to address tumor heterogeneity to inhibit tumor recurrence or metastasis. However, it remains challenge to elicit immune activation due to the weak immunogenicity of autologous tumor antigens. Here, a hybrid membrane cancer vaccine is successfully constructed by membrane fusion to enhance adaptive immune response and amplify personalized immunotherapy, which formed a codelivery system for autologous tumor antigens and immune adjuvants.

View Article and Find Full Text PDF

Hypoxia, a characteristic hallmark of solid tumours, restricts the therapeutic effect of photodynamic therapy (PDT) for cancer treatment. To address this issue, a facile and nanosized oxygen (O) bubble template is established by mixing oxygenated water and water-soluble solvents for guiding hollow polydopamine (HPDA) synthesis, and O is encapsulated in the cavity of HPDA. HPDA with abundant catechol is designed as a carrier for zinc phthalocyanine (ZnPc, a boronic acid modified photosensitizer) borate ester bonds to fabricate nanomedicine (denoted as HZNPs).

View Article and Find Full Text PDF

Parkin is a crucial E3 ubiquitin ligase for initiating mitophagy through the PINK1/Parkin pathway. Regulating the expression and activity of parkin can remedy mitophagy and human disease. We developed an efficient method to isolate natural parkin ligands from herbal medicines by combining centrifugal ultrafiltration and liquid chromatography/mass spectrometry.

View Article and Find Full Text PDF

is a medicinal herb used in various traditional Chinese medicine formulations. The polysaccharide fraction of can reduce insulin resistance and restore the gut microbiota in a rat model of aberrant lipid metabolism by down regulating miR-122. The aim of this study was to further elucidate the effect of on lipid metabolism, and the roles of specific miRNAs and the gut microbiota.

View Article and Find Full Text PDF
Article Synopsis
  • PINK1 is a putative kinase involved in regulating mitochondrial function and mitophagy, which is essential for cell health.
  • Dysregulation of PINK1 is linked to various mitochondrial-associated disorders, including liver, heart diseases, cancer, and Parkinson's disease.
  • The exploration of natural products that can regulate PINK1 is promising for developing treatments for these diseases and improving our understanding of how these natural products work.
View Article and Find Full Text PDF

Mitophagy plays an important role in maintaining mitochondrial quality and cell homeostasis through the degradation of damaged, aged, and dysfunctional mitochondria and misfolded proteins. Many human diseases, particularly neurodegenerative diseases, are related to disorders of mitochondrial phagocytosis. Exploring the regulatory mechanisms of mitophagy is of great significance for revealing the molecular mechanisms underlying the related diseases.

View Article and Find Full Text PDF

Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common global chronic liver disease. Jiuzhuan Huangjing Pills (JHP) have been used for the treatment of human disease for over a thousand years, but their efficacy and underlying mechanism(s) of action against MAFLD are unknown. We investigated the alleviating effects of JHP on high-fat diet (HFD)-induced MAFLD.

View Article and Find Full Text PDF

Mitochondria are the 'engine' of cells. Mitochondrial dysfunction is an important mechanism in many human diseases. Many natural products could remedy the mitochondria to alleviate mitochondria-involved diseases.

View Article and Find Full Text PDF

Long-term muscle fatigue is a major cause of injury. Drugs/nutrients from herbal medicines that prevent fatigue remain a major research focus. In China, a prescription composed of Polygonati Rhizoma and Notoginseng Radix et Rhizoma has been commonly used as a herb and food nutrient, providing protection against fatigue in the clinic.

View Article and Find Full Text PDF

In recent years, the incidence of diseases associated with hepatic injury has increased in prevalence. Targeting the mitochondria to protect liver function has gained momentum due to their central role in energy production, apoptotic cell death, oxidative stress, calcium homeostasis, and lipid metabolism. In this study, we employed a hepatic mitochondria-based centrifugal ultrafiltration/liquid chromatography/mass spectrometry method (CM-HMC) to identify hepatic mitochondria ligands from medicinal herbs (MHs) including Notopterygii Rhizoma et Radix (NRR) that possess hepatic-protective effects.

View Article and Find Full Text PDF
Article Synopsis
  • - Researchers are exploring natural products like PK, traditionally used in China, to treat mitochondrial dysfunction linked to non-alcoholic fatty liver disease (NAFLD) caused by high-fat diets.
  • - In a study with rats, PK was administered over 14 weeks, leading to significant restoration of mitochondrial metabolite levels and identification of ten biomarkers related to riboflavin metabolism.
  • - The findings suggest that PK improves mitochondrial functions by regulating riboflavin metabolism, making it a potential therapeutic option for NAFLD-related issues.
View Article and Find Full Text PDF

Targeting mitochondria as a hepatic-protective strategy has gained attention, because of their important roles in energy production, adjustment of apoptosis, and generation of reactive oxygen species. To promote the discovery of natural mitochondria-targeted hepatic-protectants, we established a hepatocellular mitochondria-based capturing method by coupling affinity ultrafiltration with liquid chromatography/mass spectrometry (LC/MS), which is suitable for identifying mitochondrial ligands from medicinal herbs (MHs). After evaluating the feasibility of the method, it was applied for capturing mitochondria-targeting constituents from Peucedani Radix extract.

View Article and Find Full Text PDF

Aim: To identify the effects and mechanism of action of () on dyslipidemia in rats using an integrated untargeted metabolomic method.

Methods: A rat model of dyslipidemia was induced with a high-fat diet (HFD) and rats were given [4 g/(kg•d)] intragastrically for 14 wk. Changes in serum and hepatic lipid parameters were evaluated.

View Article and Find Full Text PDF